Tumor-starving pill helps thyroid cancer: study
WASHINGTON (Reuters) - Amgen's once-a-day pill to starve
tumors can help many patients with hard-to-treat thyroid
cancer, either by shrinking tumors or slowing their growth,
researchers reported on Wednesday.
<p>You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~a/reuters/healthNews?i=KzCEPp" border="0)
</img>
</p><div class="feedflare">
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=CzZDWJ" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=42RYnj" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=kJUD7j" border="0)
</img>
</div>
![](http://feeds.reuters.com/~r/reuters/healthNews/~4/325204311" height="1" width="1)
You are not allowed to view links.
Register or
Login
